H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on VYGR stock, giving a Buy rating today. Patrick ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Voyager Therapeutics (VYGR – Research Report). The ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a ...

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 64.44% and 95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago ...

Allspring Global Investments Holdings LLC cut its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 66.5% ...

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter. On a per-share basis, the Lexington, Massachusetts-based ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Short interest in Voyager Therapeutics Inc (NASDAQ:VYGR) increased during the last ... betting on the decline of Voyager Therapeutics's stock. Short interest data is updated every two weeks.

China Shineway Pharmaceutical Group Ltd.-16.08% +0.00% China Shineway Pharmaceutical Group Ltd. +0.00% +0.00% ...

The S&P 500 financial sector shows a 0.4% decline. [BRIEFING.COM] The stock market settled into a steady decline. The S&P 500 moved below the 6,000 level early on and continues to fall. Weakness in ...